Clinical trial
Very Low Dose, add-on Prednisolone in Patients With Newly Diagnosed Rheumatoid Arthritis: a Randomised Placebo-controlled Study
NCT07252271 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Very Low Dose, add-on Prednisolone in Patients With Newly Diagnosed Rheumatoid Arthritis: a Randomised Placebo-controlled Study
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 1, 2025
- Completion date
- June 30, 2028
- Enrollment
- 112 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rhematoid arthritis